Search Results - "Spaander, M.C.W"

Autophagy mediates ER stress and inflammation in Helicobacter pylori-related gastric cancer by Mommersteeg, M.C., Simovic, I., Yu, B., van Nieuwenburg, S.A.V., Bruno, I, M.J., Doukas, M., Kuipers, E.J., Spaander, M.C.W., Peppelenbosch, M.P., Castaño-Rodríguez, N., Fuhler, G.M.

“…Autophagy is a cellular degradation mechanism, which is triggered by the bacterium Helicobacter pylori. A single nucleotide polymorphism (SNP) in the autophagy…”
Get full text

Does Routine Endoscopy or Contrast Swallow Study After Esophagectomy and Gastric Tube Reconstruction Change Patient Management? by Nederlof, N., de Jonge, J., de Vringer, T., Tran, T. C. K., Spaander, M. C. W., Tilanus, H. W., Wijnhoven, B. P. L.

“…Background Anastomotic leakage is a severe complication after esophagectomy. The objective was to investigate the diagnostic and predictive value of routine…”
Get full text

624 SELF-EXPANDABLE METAL STENTS AS DEFINITE TREATMENT FOR ESOPHAGEAL VARICEAL BLEEDING by Holster, I.L, Kuipers, E.J, van Buuren, H.R, Spaander, M.C.W, Tjwa, E.T.T.L

Get full text

Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's–associated adenocarcinoma? by Nesteruk, K., Spaander, M.C.W., Leeuwenburgh, I., Peppelenbosch, M.P., Fuhler, G.M.

“…Idiopathic achalasia and Barrett's esophagus (BE) are preneoplastic conditions of the esophagus. BE increases the risk of esophageal adenocarcinoma (EAC),…”
Get full text

Anticoagulant therapy in patients with non‐cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding by Spaander, M. C. W., Hoekstra, J., Hansen, B. E., Buuren, H. R., Leebeek, F. W. G., Janssen, H. L. A.

“…Summary Background and aims It remains unclear when anticoagulant therapy should be given in patients with non‐cirrhotic portal vein thrombosis (PVT). The aim…”
Get full text

Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes by Goverde, A, Eikenboom, E.L, Viskil, E.L, Bruno, M.J, Doukas, M, Dinjens, W.N.M, Dubbink, H.J, van den Ouweland, A.M.W, Hofstra, R.M.W, Wagner, A, Spaander, M.C.W

“…AbstractBackground & AimsPatients with Lynch syndrome are offered the same colorectal cancer (CRC) surveillance programs (colonoscopy every 2 years),…”
Get full text

Palliation of dysphagia by van der Bogt, R.D., Vermeulen, B.D., Reijm, A.N., Siersema, P.D., Spaander, M.C.W.

“…Palliation of dysphagia is the cornerstone of palliative treatment in patients with incurable oesophageal cancer. Available palliative options for dysphagia…”
Get full text

Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms by HOEKSTRA, J., BRESSER, E. L., SMALBERG, J. H., SPAANDER, M. C. W., LEEBEEK, F. W. G., JANSSEN, H. L. A.

“…Background: Myeloproliferative neoplasms (MPNs) are frequently identified as an underlying cause in patients with non‐cirrhotic portal vein thrombosis (PVT)…”
Get full text

Immunohistochemical biomarkers for risk stratification of neoplastic progression in Barrett esophagus by Janmaat, V.T., van Olphen, S.H., Biermann, K., Looijenga, L., Bruno, M.J., Spaander, M.C.W.

Get full text

Neoadjuvant chemoradiotherapy for resectable oesophageal cancer by Eyck, B.M., van der Wilk, B.J., Lagarde, S.M., Wijnhoven, B.P.L., Valkema, R., Spaander, M.C.W., Nuyttens, J.J.M.E., van der Gaast, A., van Lanschot, J.J.B.

“…At present, treatment of potentially curable oesophageal cancer includes neoadjuvant chemoradiotherapy followed by oesophagectomy. Alternatively, neoadjuvant…”
Get full text

Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study by Bleijenberg, A G C, IJspeert, J E G, Carballal, S, Pellise, M, Jung, G, van Herwaarden, Y J, Bisseling, T M, Nagtegaal, I D, van Leerdam, M E, Spaander, M C W, van Lelyveld, N, Bessa, X, Rodríguez-Alcalde, D, Bastiaansen, B A J, de Klaver, W, Bemelman, W A, Bujanda, L, Koornstra, J J, Rivero, L, Rodríguez-Moranta, F, Balaguer, F, Dekker, E

“…Serrated polyposis syndrome (SPS) is accompanied by a substantially increased colorectal cancer (CRC) risk. To prevent or treat CRC in patients with a very…”
Get full text

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening by van Toledo, D.E.F.W.M., IJspeert, J.E.G., Spaander, M.C.W., Nagtegaal, I.D., van Leerdam, M.E., Lansdorp-Vogelaar, I., Dekker, E.

“…Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. However, risk estimation per…”
Get full text

Role of acid suppression in the development and progression of dysplasia in patients with Barrett's esophagus by Kastelein, F, Spaander, M C W, Biermann, K, Vucelic, B, Kuipers, E J, Bruno, M J

“…Barrett's esophagus (BE) usually develops in patients with gastroesophageal reflux disease and therefore it has been suggested that esophageal acid exposure…”
Get more information

Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy by van der Zijden, C. J., van der Sluis, P. C., Mostert, B., Nuyttens, J. J. M. E., Spaander, V. M. C. W., Valkema, R., Ruurda, J. P., Wijnhoven, B. P. L., Lagarde, S. M.

“…Background Approximately 4–9% of patients have a tumor-positive resection margin after neoadjuvant chemoradiotherapy (nCRT) and esophagectomy. Although it is…”
Get full text

Induction chemotherapy followed by surgery for advanced oesophageal cancer by Toxopeus, E.L.A, Talman, S, van der Gaast, A, Spaander, V.M.C.W, van Rij, C.M, Krak, N.C, Biermann, K, Tilanus, H.W, Mathijssen, R.H.J, van Lanschot, J.J.B, Wijnhoven, B.P.L

“…Abstract Background Patients with locoregionally advanced oesophageal tumours or disputable distant metastases are referred for induction chemotherapy with the…”
Get full text

Review article: the management of non‐cirrhotic non‐malignant portal vein thrombosis and concurrent portal hypertension in adults by SPAANDER, V. M. C. W., VAN BUUREN, H. R., JANSSEN, H. L. A.

“…Summary Background  Extrahepatic portal vein thrombosis is an important cause of non‐cirrhotic portal hypertension. Aim  To provide an update on recent…”
Get full text